Health Technology Investment Act Introduced in the House

The bipartisan Health Technology Investment Act (H.R. 6197) was recently introduced in the House of Representatives by Reps. John Joyce (PA-13), Scott Peters (CA-50), Beth Van Duyne (TX-24), Brad Schneider (IL-10), Jay Obernolte (CA-23), and Angie Craig (MN-02). This legislation matches a companion bill (S. 1399) that was introduced by Senators Martin Heinrich (NM) and Mike Rounds (SD) earlier this year. Right Scan Right Time appreciates these members of Congress for their leadership in introducing this landmark legislation to address a critical need in American healthcare. 

The Health Technology Investment Act (HTIA) aims to ensure patients, providers, and the healthcare system can benefit from the life-changing potential of artificial intelligence (AI) and machine learning-enabled medical devices. AI-enabled medical tools are helping providers detect, diagnose, and treat diseases earlier, helping to ensure efficiency and accuracy in interpreting medical images and enhancing patient outcomes.

However, the adoption of these AI-enabled medical technologies has faced significant barriers under the current CMS payment framework because there is such a limited scope of advanced devices that qualify for reimbursement.

If enacted, HTIA would develop a formalized payment pathway for FDA-authorized algorithm-based healthcare services by establishing a clear and consistent Medicare payment pathway for five years. This would allow manufacturers and providers the certainty they need to invest in healthcare technologies and further support a future of continued transformative healthcare innovation.

Please consider joining Right Scan Right Time to ask your members of Congress to support this legislation. Your voice can help make a difference! 

To send a letter encouraging your representatives to co-sponsor H.R. 6197, click here.